Global Halitosis Treatment Market - Overview
According to American Dental Association (ADA), halitosis is a “chronic bad breath”, an unpleasant smell in the breath which is detectable by other people. Bad breadth is a major problem across the globe affecting social life of the people. It may lead to stress and psychological pressure further resulting into negative impact on person’s life. Wide range of oral care products are available for the treatment of halitosis. Major market players are engaged in the manufacturing of oral care products in different flavours to attract more and more customers while maintaining the product quality. According to a recent study report published by the Market Research Future analysts, the global halitosis treatment market is growing at a rapid pace with a double digit growth rate. This growth is mainly due to the increasing prevalence of halitosis and periodontal diseases. According to Journal of Natural Science, Biology and Medicine, Halitosis is very common among the general population and nearly more than 50% of the general population have halitosis. Moreover, technological advancement in the field of dentistry, for instance use of breathalysers to detect the levels of bacteria’s which causes bad breath has spurred the growth of global halitosis market. Also Read @ https://www.medgadget.com/2019/07/halitosis-treatment-market-2019-to-rise-at-cagr-of-18-58-worldwide-overview-by-size-growth-factors-diagnostic-tests-drug-treatment-and-regional-forecast-by-2023.html Segmentation: The global Halitosis Treatment Market growth can be segmented by halitosis, indication, diagnostic test, and drug treatment. Based on type of halitosis, the halitosis treatment market is segmented into pathological halitosis and others. Pathological halitosis can be sub-segmented into oral pathological halitosis and extra oral pathological halitosis. Other types include physiological halitosis. Indication-wise, the halitosis treatment market includes respiratory, liver, kidney, gastrointestinal, systemic, and others. The respiratory segment can be sub-segmented into sinusitis, tuberculosis, emphysema, pharyngitis, pneumonia, and others. The liver segment includes liver failure, gallbladder diseases, and others. Kidney segment comprises Uremia. The gastrointestinal segment can be further segmented into esophageal reflux, stomach cancer, malabsorption, and pharyngitis. The systemic segment includes diabetes. Based on the diagnostic test, the halitosis treatment market includes halimeter, gas chromatography, BANA test, β-galactosidase activity assay, and other tests. Based on drug treatment, the halitosis treatment market includes antacids, antiseptic, ranitidine and other drugs. Other drugs available of the treatment of halitosis are cetylpyridinium chloride and cimetidine. Regional Analysis: Region-specific segmentation of the halitosis treatment covers namely the America, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA). The Americas accounted for a significant market share as the region is witnessing a hike in gum diseases and extensive use of oral care products such as toothpaste, mouthwashes, mouth sprays, etc. Europe’s climb to the second spot can be attributed to the growing awareness regarding halitosis and products available for its treatment. The APAC region can expect rapid growth as factors such as rising cases of chronic diseases, coupled with population boom are impacting the intake of halitosis treatment. The MEA market can only expect moderate growth due to poor economic conditions, and lack of awareness about oral health. Competitive Analysis: Some of key players profiled in the halitosis treatment market report are Colgate-Palmolive Company (U.S), All USA Partners LLC (U.S), Dr. Harold Katz, LLC (U.S), Rowpar Pharmaceuticals, Inc. (U.S), Abbott (U.S), Listerine (U.S), AstraZeneca (U.S), and others. Strategies play a significant role in their market hold. The insights they have also help the halitosis treatment market percolate more across regions. Browse Complete 90 Pages Premium Research Report Enabled with 30+ Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/halitosis-treatment-market-3758 Related Reports Bone Pain Treatment Market Research Report- Global Forecast To 2027 Bone Cancer Market Research Report- Global Forecast To 2027 Medical Waste Management Equipment Market Research Report- Global Forecast To 2027 About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
0 Comments
Global Cardiovascular Ultrasound Market - Overview
Cardiovascular ultrasound imaging system market has increased due to increase in the incidence of cardiovascular diseases, changing lifestyle of people, increase in incidence of diabetes and other risk factors favouring the growth of this market. Increase in demand of cardiovascular ultrasound imaging system in hospitals for diagnosis of heart disease or before any surgical procedure favour the growth of this market. also read @ https://www.medgadget.com/2019/02/cardiovascular-ultrasound-market-key-leading-countries-their-global-share-analysis-to-earn-profit-of-us-1-72-billion-by-2023-2.html Key Players The key players operating in the global cardiovascular ultrasound treatment market are Canon Medical Systems Corporation, Koninklijke Philips N.V., Hitachi, Fujifilm Medical Systems, GE Healthcare, Inc., Siemens Healthcare, Mindray Medical, Chison Medical IMaging Co. Ltd., Samsung Medison, KPI Healthcare Inc., and Whale Imaging. Global Cardiovascular Ultrasound Market – Segmentation Cardiovascular Ultrasound Market Trendshas been segmented based on type of imaging, imaging technology, and end user. By type of imaging, the global cardiovascular ultrasound market has been segmented into transthoracic, trans esophageal, echocardiograms, stress, and abdominal vasculature ultrasound imaging. By imaging technology, the global cardiovascular ultrasound market has been segmented into 2D, 3D and Color Doppler. By end user, the global cardiovascular ultrasound market has been segmented into hospitals and clinics, diagnostic centers and others. Global Cardiovascular Ultrasound Market – Regional Analysis By region, the Global Cardiovascular Ultrasound Market has been segmented into the Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa (MEA). North America is the largest market for cardiovascular ultrasound market. High prevalence of cardiovascular diseases and robust healthcare infrastructure supports the growth of the market in the region. Moreover, high healthcare expenditure, favorable reimbursement policies, and the presence of various medical device manufacturers in the region also acts as a plus for the growth of the market. APAC is expected to be the fastest growing market for cardiovascular ultrasound market. Surging prevalence of cardiovascular diseases and the presence of a massive patient pool are factors driving growth within the APAC market. In addition, diabetes is also a common prevalent condition in the region which exposes patients at greater risk of acquiring heart diseases. High expenditure on healthcare infrastructure and government support for the same us fostering the growth of the market in the region. Browse Complete 80 Pages Premium Research Report Enabled with Tables and Figures @ https://www.marketresearchfuture.com/reports/cardiovascular-ultrasound-market-1548 RELATED REPORTS Global Intracranial Hemorrhage Diagnosis & Treatment Market Research Report—Forecast to 2027 Global Ear Infection Treatment Market Research Report—Forecast till 2027 Compounding Chemotherapy Market Research Report—Forecast till 2027 About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Contraceptive Pills Industry Analysis Covid19 Impact, Research Report, Outlook and Demand 20275/28/2021 Market Synopsis of Contraceptive Pills Market:
Market Scenario: Anti-conception medication pills which are also called as oral contraceptive pills are a kind of female hormonal anti-conception medication technique and are extremely viable at avoiding pregnancy. The Pills are small tablets that a patient swallow every day. Most pills contain two sorts of manufactured (man-made) female hormones: estrogen and progestin. These are like the estrogen and progesterone regularly made by the ovaries. These pills are called "combination oral contraceptives," and there are a wide range of these kinds. Segments: Contraceptive Pills market has been segmented on the basis of drug class which comprises combination pills and Progestin only pills. Combination pills are further segmented into Monophasic and Multiphasic pills. also read @ https://www.medgadget.com/2019/11/oral-contraceptive-pills-market-size-share-growth-emerging-trend-top-leading-players-future-prospects-business-intelligence-news-by-2022.html Global Contraceptive pills Market – Overview Contraceptive pills are likely to witness considerable demand in the years to come. The observation offered by Market Research Future (MRFR) unfolds that the global contraceptive pills market is expected to enter a phase of maturity in the foreseeable future. According to the report, the market is prognosticated to record a CAGR of 2.2% across the projection period 2016 to 2022. Anti-conception medication pills which are also called as oral contraceptive pills are a kind of female hormonal anti-conception medication technique and are extremely viable at avoiding pregnancy. These pills are small tablets that a patient swallow every day. These birth control pills are been used from ancient times but the save and effective methods are introduce and available from 20th century. Contraceptive drugs are used to prevent the unwanted pregnancy by blocking the normal process of ovulations or by altering the process which support the fertilization of egg. Most pills contain two sorts of manufactured (man-made) female hormones: estrogen and progestin. These are like the estrogen and progesterone regularly made by the ovaries. These pills are called “combination oral contraceptives,” and there are a wide range of these kinds. Globally the market for contraceptive pills is growing at a low rate but with increasing prevalence of sexually transmitted diseases will upsurge the growth of this market in coming future. According to a recent study report published by the Market Research Future, the global contraceptive pills market is booming and expected to gain eminence over the forecast period. The market is forecasted to demonstrate a spectacular growth by 2022, surpassing its previous growth records in terms of value with a prominent CAGR during the anticipated period (2017 – 2022). Increasing need of population control and increasing incident of abortion has driven the growth of the market. Governmental initiatives for minimizing unwanted pregnancy, increasing awareness and healthcare expenditure, and increasing in use of contraceptives drugs has provided fuel for the growth of the market. While the side effects of the treatment and strict governmental rules in many countries may hamper the growth of the market. Geographically, North America commands the largest market for the Contraceptive Pills Industry. Approximately 3 million women in North America experiences unplanned pregnancy. Beside this 90 % of the women use some of the method of contraception. Thus increasing number of abortion and rate of unplanned pregnancy has driven this market in North America. Major market of North America is contributed by US which is followed by Canada. Increasing awareness and minimizing the healthcare expenses by curbing number of abortion in US encourage contraceptive use among women. North America contraceptives drug market is expected to grow at a CAGR of 5.9 % during forecasted period. The market for contraceptive pills is characterised by the presence of several well-established and small players, the global market of contraceptive pills appears to be highly competitive and fragmented. Major players are increasingly expanding their footprint in the emerging nations, making it putting pressure on the regional players, especially in terms of features such as type, product portfolios, and pricing. The market is witnessing intensified competition which is expected to get more intensified further during the forecast period. The contraceptive pills market appears to be highly competitive owing to the presence of several large and small key players accounting for a substantial market share. Well established players are getting into various product launches in order to gain competitive advantage in this market and to maintain their market position. For instance, in 2015, Pfizer Inc. has introduced SAYANA, first injectable contraceptive in UK which can be self-administered. While, in 2015, Teva Pharmaceutical Industries Ltd. has launched Beyaz which is a generic contraceptive drug. It is one of the most successful product of the company and in 2016 it has annual sales of approximately $133 million in the US. Recently, in March 2017, the company has launched a new product Minastrin in the market. Moreover, the company has launched the generic version of Janssen’s birth control pills Ortho Tri-Cyclen Lo. Into the brand name of Tri-Lo-Sprintec (norgetimate and ethinyl estradiol) tablets. Therefore, the growing partnerships and product launches to expand their presence in various parts of the globe for their competitive products has spurred the growth of the market. Browse Complete Report at https://www.marketresearchfuture.com/reports/contraceptive-pills-market-2122 . RELATED REPORTS Global Intracranial Hemorrhage Diagnosis & Treatment Market Research Report—Forecast to 2027 Global Ear Infection Treatment Market Research Report—Forecast till 2027 Compounding Chemotherapy Market Research Report—Forecast till 2027 About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Market Drivers
- A growing number of cases with ophthalmic disorders causing chronic retinal diseases across the globe is the primary factor driving the market growth. According to the World Health Organization, globally around 2.2 billion people are having a vision problem. The huge patient population suffering from eye problem supports the market growth. - Increasing prevalence of retinal vein occlusion (RVO) and age-related macular degeneration. RVO is the second most common retinal vascular disorder and is a significant cause of visual impairment. Around 11 million people in the US have some form of age-related macular degeneration. This number is expected to increase to nearly 22 million by 2050. - The growing R&D activities and product launch support market growth during the forecast period. Regional Analysis The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The retinal biologics market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The Americas is expected to be the largest market owing to the presence of a large number of, companies providing retinal biologics such as Regeneron Pharmaceuticals Inc. (US), Ocular Therapeutixc. (US), Spark Therapeutics (US), and many more. Additionally, the rising prevalence of diabetic retinopathy and the aging population supports the retinal biologics market in this region. For instance, currently, around 12 million people of 40 years and above has a vision problem in the US. A large number of vision problem cases and the presence of a number of manufacturing companies drive the market growth in this region. The European Retinal Biologics Market Analysis is the second-largest market, and it has been categorized as Western Europe and Eastern Europe. The Western European market has further been divided as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The increasing R&D to develop novel retinal biologics, and growing product approval boosts the market growth. Moreover, the increasing cases of macular degeneration, diabetic retinopathy, and uveitis among the population support market growth. The retinal biologics market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. According to the World Blind Union Asia Pacific Region 2018, it was reported that in China, more than 35 million people have some disability out of which 17.5 million are vision impairment which includes blind people with various disabilities. The increasing geriatric population will lead to an increase in age-related macular degeneration which will, in turn, increase the patient population. The retinal biologics market in the Middle East & Africa has been divided into the Middle East and Africa. The growing number of research laboratories in this region drives market growth. The increasing adaption of innovative treatment methods drives the market growth. Segmentation Global Retinal Biologics Market has been segmented based on Drug Class, Indication, and Distribution Channel. Global Retinal Biologics Market has been segmented, on the basis on drug class, into TNF-α inhibitor and VEGF-A antagonist. On the basis of indication, the market is segmented into macular degeneration, diabetic, retinopathy, uveitis, and others. On the basis of distribution channel, the market is segmented into hospitals and clinics, pharmacies, and others. Key Players Some of the Key Players in the Global Retinal Biologics Market are Regeneron Pharmaceuticals Inc. (US), Ocular Therapeutixc (US), Spark Therapeutics (US), F. Hoffmann-La Roche Ltd (Basel, Switzerland), AbbVie Inc. (US), Johnson & Johnson Services, Inc. (US), Amgen Inc. (US), MeiraGTx Limited (US) and many more. Browse Full Report Details @ https://www.marketresearchfuture.com/reports/retinal-biologics-market-10171Related Reports Eye Allergy Treatment Market Research Report - Forecast to 2027 Pharmaceutical Analytical Testing Outsourcing Market Research Report - Forecast till 2027 Urinary Catheters Market Research Report - Forecast to 2027 About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. Market Synopsis of Global Keratoacanthoma Market:
Market Scenario: Keratoacanthoma (KA)is a condition in which a tiny dome or a crater is formed on the skin which is a result of a low grade, slow growing cancer tumor on the skin. It is benign in nature despite its appearance and other similarities with Squamous Cell Carcinoma (SCC). KA initially originates in the hair follicles of the skin and very rarely spreads to the other cells. The prevalence of this condition is mostly in the people aged 60 or more but it can even occur in people who are exposed to sun, coming in contact with chemical carcinogens, or through infection.The growing ageing population and people notavoiding direct sun exposure for prolonged hours has driven the growth of the market. The global market is expected to reach US$ XX by the end of the forecasted period and is expected to grow at a CAGR of XX%. Reasons to Purchase this Report Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors Provision of market value (USD Billion) data for each segment and sub-segment Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market Analysis by geography highlighting the consumption of the product / service in the region as well as indicating the factors that are affecting the market within each region The competitive landscape which incorporates the market ranking of the major players, along with new service / product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled The research analysts provide an elaborate description of the value chain and its distributor analysis. Segments: Keratoacanthoma Treatment Analysis has been segmented on the basis of treatment which comprises of Medication, Surgery (Cryosurgery and Mohs’ Microscopic Surgery) Intralesional Injection, Radiation Treatment and X-ray therapy and others. On the basis of end user, the market is segmented into Hospitals, Medical Research Laboratories and others. Market Information, by treatment (Medication, Surgery – Cryosurgery and Mohs’ Microscopic Surgery, Intralesional Injection, Radiation Treatment and X-ray therapy Access Complete Detailed TOC Research Report at https://www.marketresearchfuture.com/reports/keratoacanthoma-market-1765 Related Reports Eye Allergy Treatment Market Research Report - Forecast to 2027 Pharmaceutical Analytical Testing Outsourcing Market Research Report - Forecast till 2027 Urinary Catheters Market Research Report - Forecast to 2027 About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. Market Highlights
Antihelminthics are prescribed to kill parasites (helminthes). Common parasitic infestations include amebiasis, malaria, giardiasis, hookworm, pinworm, threadworm, whipworm and tapeworm infestations. The drugs function either by destroying the worms on contact or by paralyzing them, or by altering the permeability of their plasma membranes. According to World Health Organization (2014), over 1.5 billion people are infected with soil-transmitted helminths worldwide. Additionally, According to the latest report published by WHO, more than 880 million children are in need of treatment for these parasitic diseases. Increasing prevalence of parasitic diseases, rising demand for the treatment, and increasing number of patients drives the growth of the market. Moreover, changing lifestyle and increasing geriatric population have increased the probability of causing digestive tract infections, thus helps in driving the growth of the market. Additionally, the increasing need for the cost-effective treatment and increasing per capita income have fuelled the market growth. However, antihelminthics drugs are slightly toxic and some of the side effects are observed in some patients. This factors may restrain the growth of the market. The global antihelminthics market is expected to grow at a CAGR of ~ 5.3% during the forecast period 2017-2023. Antihelminthics are a group of antiparasitic drugs that are prescribed to kill parasites (helminthes) in common parasitic infestations such as fasciolasis, filariasis, angiostrongylosis, and others. The global Antihelminthic Drugs Market Size is likely to capture a CAGR of 5.3% and reach high growth figures over the forecast period of 2017-2027, projects Market Research Future (MRFR) in an exclusive study. Parasitic diseases such as schistosomiasis, whipworm infection, ascariasis, and other intestinal infections are most prevalent in East Asia, sub-Saharan Africa, and India. Parasitic diseases occur in unhygienic conditions in the developing countries where a majority of the population suffering from such diseases induce high demand for antihelminthics and boost the growth of the global antihelminthics market. In the last few years, extensive research programs have been initiated which has resulted in thedevelopment and modification of existing drugs. The pharmaceuticalindustry has been able to produce a wide spectrum of highly effective antihelminthics which has been a plus for the growth of the global antihelminthics market. Other factors spurring the growth of the global anthelminthic market include growing geriatric population and rapidly expanding healthcare sector, especially in developing economies. On the other hand, the growth of the global antihelminthics market might be impeded by the side effects associated with antihelminthics. Also, overuse of antihelminthics leads to the emergence of resistant microbes which might affect the efficacy of antihelminthics. READ MORE @ https://www.marketresearchfuture.com/reports/antihelminthics-market-4500 Browse More Related Reports at: Orthopedic Braces Market Research Report - Global Forecast till 2027 Clinical Trials Market Research Report - Forecast to 2027 Digital Diabetes Management Market Research Report – Global Forecast till 2027 Competitive Landscape: Sanofi (US),Merck & Co., Inc. (US),GlaxoSmithKline Plc. (US),AstraZeneca (UK),Bayer AG (Germany),Sanofi (France),ALLERGAN (Ireland),Mentis Pharma Ltd. (India),Abbott (US),ZEISS International (Germany),AstellasPharma Inc. (Japan),Johnson & Johnson Services, Inc. (US),Novartis AG (Switzerland), and Pfizer Inc. (US). |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
October 2021
Categories |